CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $89,500
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-03 | Feinberg Peter Director | Conversion · Series B Preferred Stock | −30,646 | 0 | ||
| 2021-08-03 | Feinberg Peter Director | Conversion · Series B Preferred Stock | −30,646 | 0 | ||
| 2021-08-03 | Zeskind Benjamin J. President and CEO | Conversion | +49,099 | 2,598,171 | ||
| 2021-08-03 | Zeskind Benjamin J. President and CEO | Purchase | +2,098 | $15.00 | $31K | 2,600,269 |
| 2021-08-03 | Zeskind Benjamin J. President and CEO | Conversion · Series A Preferred Stock | −40,928 | 0 | ||
| 2021-08-03 | Zeskind Benjamin J. President and CEO | Conversion · Series B Preferred Stock | −8,171 | 0 | ||
| 2021-08-03 | KEATING LAURIE Director | Purchase | +7,000 | $15.00 | $105K | 7,000 |
| 2021-08-03 | Hall Brett Matthew Chief Scientific Officer | Conversion | +5,040 | 5,040 | ||
| 2021-08-03 | Hall Brett Matthew Chief Scientific Officer | Purchase | +1,353 | $15.00 | $20K | 6,393 |
| 2021-08-03 | Hall Brett Matthew Chief Scientific Officer | Conversion · Series A Preferred Stock | −1,636 | 0 | ||
| 2021-08-03 | Hall Brett Matthew Chief Scientific Officer | Conversion · Series B Preferred Stock | −3,404 | 0 | ||
| 2021-08-03 | CARPENTER ROBERT J Director | Conversion | +217,173 | 823,839 | ||
| 2021-08-03 | CARPENTER ROBERT J Director | Purchase | +325,000 | $15.00 | $4.9M | 1,148,839 |
| 2021-08-03 | CARPENTER ROBERT J Director | Conversion · Series A Preferred Stock | −94,585 | 0 | ||
| 2021-08-03 | CARPENTER ROBERT J Director | Conversion · Series B Preferred Stock | −122,588 | 0 | ||
| 2021-08-03 | Bookman Michael General Counsel and Secretary | Purchase | +1,402 | $15.00 | $21K | 1,402 |
| 2021-08-03 | BERMAN ANN E Director | Purchase | +3,500 | $15.00 | $53K | 3,500 |
| 2021-08-03 | Barrett Scott Chief Medical Officer | Conversion | +5,996 | 5,996 | ||
| 2021-08-03 | Barrett Scott Chief Medical Officer | Purchase | +667 | $15.00 | $10K | 6,663 |
| 2021-08-03 | Barrett Scott Chief Medical Officer | Conversion · Series A Preferred Stock | −3,273 | 0 |
Page 11 of 12 · 226 trades